We investigated the ability of diamond nanoparticles (nanodiamonds, NDs) to deliver small interfering RNA (siRNA) in Ewing sarcoma cells, in the perspective of in vivo anti-cancer nucleic acid drug delivery. siRNA was adsorbed onto NDs previously coated with cationic polymer. Cell uptake of NDs has been demonstrated by taking advantage of NDs intrinsic fluorescence coming from embedded color center defects. Cell toxicity of these coated NDs was shown to be low. Consistent with the internalization efficacy, we have shown a specific inhibition of EWS/Fli-1 gene expression at the mRNA and protein level by the ND vectorized siRNA in a serum containing medium.
Introduction
In the anti-cancer drug delivery domain, nanotechnologies are a promising tool for future applications such as a more favourable tissue distribution and a decrease of the toxicity.
1 Various types of nanoparticles have been developed 2 such as liposomes, lipidic micelles, dendrimers and polymers. Active molecules are either covalently bound to the nanoparticles, 3, 4 adsorbed onto their surface 5, 6 or encapsulated.
7
The requirements for the efficacy of a vector are (i) a large quantity of active molecules per vector entity, (ii) the capacity to reach the targeted cells, (iii) the capacity to deliver the active molecule to the target in these cells. As far as side effects are concerned the nanoparticle needs to have a low toxicity, to be bio-compatible, and to be quickly eliminated from the body after their action has taken place. Therefore, in order to find the most potent compounds a large variety of vectors needs to be investigated. For instance the use of mineral nano-object as carrier for drug delivery has been proposed including silica, metals, and carbon.
4,8-10
In this work we used diamond nanocrystals (nanodiamonds) 11, 12 as a cell targeting bi-functional device, serving as a drug delivery vehicle and a fluorescent label at the same time. Nanodiamond display attractive properties such as a small size, down to less than 10 nm, various possibilities of surface funtionnalization 13 and a perfectly stable photoluminescence well adapted for studying intracellular traffic and localization. The fluorescence properties results from the creation of nitrogen-vacancy (NV) color centers inside the nanodiamond matrix. The nitrogen is naturally present in synthetic diamond produced under high-pressure and high temperature conditions. The vacancy is created by high-energy ion beam irradiation, and the NV complex is formed after thermal annealing.
Various approaches have been recently reported for the production of bright fluorescent nanodiamonds (fNDs) in quantities sufficiently large for the need of bio-applications.
14-16
Compared to semiconductor nanocrystals (QDots), NV color centers contained into NDs present a perfectly stable emission (no blinking, no bleaching), with a similar brightness at saturation of their fluorescence. 17 They can therefore be used for long-term tracking in cells and organisms.
15,18
Furthermore, NDs seem to be better tolerated by cells than other carbon nanomaterials. 19 Fluorescent NDs introduced into Caenorhabditis elegans worm, by either feeding or microinjection into the gonads proved to be stable nontoxic and did not cause any detectable stress to the worms. 18 In mice, intravenous injection of 50 nm size NDs led to longterm (28 days) entrapment in the liver and the lung, 20 but no mice showed any symptoms of abnormality. However, further toxicological studies are necessary due to the accumulation. Moreover, when instilled in the mouse trachea 4 nm NDs did not show evident adverse effects in the lungs, owing to their efficient elimination by macrophages.
21
Considering these encouraging results in cellular and small animal models, in vitro experiments have been recently performed with NDs to show their capacity to deliver anticancer drugs, in cell 3, 22 and in mouse model of liver and mammary cancers where ND delivery enhances the chemotherapeutic efficiency of the drug.
Recent studies have shown the potential of nanodiamonds coated by cationic polymers to deliver genes into the cells, 5 including siRNA, 24 without adverse effects, and with higher efficiency than the standard lipofectamine transfecting agent in physiological conditions. siRNA are short double strand RNAs inducing gene-silencing activity by interfering with mRNA in the cell cytoplasm by triggering a sequence specific cleavage at the level of sequence recognition on target mRNA after association to the RISC complex.
25
In this work we establish the relevance of such a strategy in a therapeutic context. We used NDs as a cargo to deliver siRNA in human cell lines originating from Ewing Sarcoma tumors. Ewing Sarcoma, a genetic disease considered as the most frequent bone cancer in children, is induced in 90% of case by chromosomal translocation at the level of chromosomes t (11, 22 
31-33
We developed cationic NDs able to bind siRNAs at their surface. We compared two types of polymers capable of interacting with anionic oligonucleotides polyethylene-imine (PEI) and polyallylamine hydrochloride (PAH). PEI is currently used as an oligonucleotide transfection agent. However, the water-soluble PEI does not form siRNA polyplexes stable enough in extracellular media for effective delivery, but the system consisting in noncovalent coating of PEI to the surface of a nanoparticle has proved to be a very efficient DNA and siRNA delivery device. 5, 24, 34 We also used PAH coating because it was shown to form a reproducible complex leading to a stable aqueous suspension with a low cell toxicity.
35
Herein, we analyzed the data obtained with these two types of coating, using fluorescent NDs, in terms of their capacity (i) to bind to siRNA, (ii) to allow its cell uptake, and (iii)
to inhibit EWS-Fli1 expression in cell culture at both the mRNA and protein levels.
2 Results and discussion
Characterization of cationic nanodiamonds
Both types of ND (as received powder, or electron irradiated and annealed ones) have undergone an oxidative treatment to remove the graphitic shell, resulting in a surface rich in carboxylic groups, and forming anionic particles. Cationic NDs were produced by surface coating with amino rich polymers: Poly(allylamine hydrochlolide)(PAH) red, following our previous work procedure, 35 or Polyethileneimine (PEI). As indicated in Table 1, the pH are 5.6 and 6.7 for ND-PAH and ND-PEI aqueous suspensions respectively.
ND zeta potential shifts from -27 mV before polymer coating to +31 mV or +26 mV after coating by PAH or PEI, respectively. This surface coating is associated to an increase of their size from 50 nm to 130 nm and 120 nm respectively, which is most likely due to the formation of small aggregates during the coating. When the particle charge turns from negative to positive value, repulsion between particles is lower, and aggregation is generally observed. It is well known that nanoparticles have a propensity to form strongly bound aggregates hard to break even by strong sonication. However beads assisted sonication has recently been successful for de-agglomeration and simultaneous covalent functionalization of nanodiamonds at their primary particle level.
36
FT-IR spectroscopy reported in a previous study 35 associated to a saturation mass ratio of 1:140 and a phosphate to amino charge ratio of 1:8. The conclusion is that at a given ND concentration, ND-PAH is able to adsorb a higher amount of siRNA than ND-PEI. Note that the slightly larger zeta potential of ND-PAH compared to that of ND-PEI also supports this conclusion.
Cytotoxicity of the ND on NIH/3T3 cells
In order to evaluate the toxicity of the nanodiamond, we have studied the cell viability of NIH/3T3 murine fibroblasts in the presence of NDs, NDs coated with the polycations (PAH or PEI), and ND-siRNA complexes. In the latter case, the typical concentration of 50 nM of siRNA was used. 37 Figure 2 shows that only ND-PAH, non complexed with siRNA, presents some toxicity, but at a high concentration with a IC50 of 0.1 µg µl −1 .
This effect might be due to cationic charges at the ND surface, as it has already been observed with polycation-coated silver nanoparticles. 38 When the cationic charge is neutralized by siRNA adsorption, the toxicity decreases. The relative decrease is larger in the case of PAH coating, since PAH is more toxic than PEI. However, for all ND-siRNA complexes the cell viability is larger than 70%, even at the maximal concentration used. These results have to be compared to a 45% toxicity which is observed after cell incubation with
Lipofectamine siRNA lipoplexes at a dose corresponding to 50 nM siRNA final concentration (see Supporting Information) in conditions recommended by the supplier (serum free medium for 3 hours followed by 21 hours of culture in complete medium).
Cytotoxicity studies were also performed on cells expressing the EWS-Fli1 oncogene, i.e.
the murine fibroblast NIH/3T3 EF cells and the A673 human cells (see Supp. Info.).
This later study allowed us to select the concentration range of siRNA-cationic NDs with a toxicity low enough not to interfere with the inhibition effect sought. Similar results were obtained, i.e. concentration lower than 0.1 µg µl −1 .
siRNA delivery into cells by cationic fluorescent nanodiamonds
Cellular uptake efficiency and intracellular distribution of the siRNA-ND complexes have been evaluated using the fluorescence of FITC-labeled siRNA and that of fNDs. Figure 3 displays a cell observed by confocal microscopy after 4 hour incubation with siRNA complexed to ND-PAH or ND-PEI. The signal in the red channel appears to be perfectly stable in time, which is a characteristic of fNDs fluorescence. As observed in previous studies nanodiamonds are localized in the perinuclear region and do not enter into the cell nucleus. In order to evaluate the dynamics of the release in cell of siRNA from the fNDs, we did confocal scans of cell cultures fixed at five different times (from 6 to 72 h), after the 4 h initial incubation duration with the NDs. For this study we used FITC-labeled siRNA complexed to fND-PAH (resp. fND-PEI) at the optimal mass ratio of 1:25 (resp. 1:75). Further studies have shown that NDs-polycation siRNA are internalized in Ewing sarcoma cells by endocytosis (data not shown). One hypothesis to account for the efficiency of polycations bearing amino groups as oligonucleotide delivery vehicles, is that they trigger the endosome disruption before the complex is transferred to the acidic lysosome compartment. The proposed mechanism relies on the protonation of the amino-polycation inside the cell due to its large pKa (pKa 9 for PEI 40 ), leading to an influx of counter-ions resulting in osmotic swelling followed by endosome membrane disruption and cytoplasmic release of the oligonucleotide-polycation complex. 34, 41 Furthermore, in our case, the affinity of siRNA for ND-PAH being stronger than for ND-PEI, the desorption of siRNA from the nanodiamond carrier in the cytosol happens to be slower in the case of PAH coated ND.
Inhibition of EWS-Fli1 by cationic ND vectorized siRNA
The efficiency of siRNA vectorized by cationic NDs has been evaluated by their ability to interfere destructively with the targeted EWS-Fli1 mRNA involved in Ewing sarcoma.
After cell treatment with 50 nM EWS-Fli1 siRNA vectorized either by ND-PAH or ND-PEI, we have measured by qPCR the EWS-Fli1 mRNA ratio in treated and untreated cells as described in the Experimental Section. The capacity of siRNA to inhibit mRNA expression was tested with the two cell lines expressing EWS-Fli1: NIH/3T3 EF and A673. Figure 5 (a) shows that 50 nM free siRNA do not inhibit EWS-Fli1 expression.
When it is vectorized by either ND-PAH or ND-PEI, EWS-Fli1 mRNA expression is inhibited, with the maximum efficiency of 50% for ND-PEI in the case of NIH/3T3 EF cells and resp. 55% with A673 cells ( Figure 5(b) ). ND-PAH appears to be a less efficient transfection agent. In the same conditions a control siRNA, with no anti-sens action, gives no inhibition effect.
When Lipofectamine R is used to vectorize the same quantity of siRNA in a free serum medium, we obtained 65% inhibition of the targeted mRNA, but associated to a 50%
cytotoxic effect compared to only 20% for ND-PAH or ND-PEI. Moreover, if the cells are treated by Lipofectamine in serum containing medium, the inhibition of EWS-Fli1 mRNA expression is only 20% to be compared with 50% for ND-PEI vectorized siRNA, proving that ND-PEI is a better transfection agent for siRNA in physiological conditions.
To confirm the specific EWS-Fli1 inhibition by nanodiamond-vectorized siRNA, we have The larger inhibition efficiency of siRNA:ND-PEI compared to siRNA:ND-PAH is also in perfect agreement with a slower release of siRNA in the later case, as observed in confocal microscopy ( Figure 4 ).
Conclusions
We have synthesized a fluorescent nanodiamond vector with two different cationic coatings, for siRNA delivery into Ewing sarcoma cell in culture. This vector shows advantages compared to the usual transfection agent lipofectamine, inducing a larger efficiency in inhibiting the EWS-Fli1 expression, combined with a lower toxicity to the cell in serum supplemented medium. We observed that the larger adsorption affinity of siRNA onto PAH-coated NDs than onto PEI-coated NDs results in a much slower dissociation of the siRNA:ND-PAH complex than of the siRNA:ND-PEI ones, and hence a lower siRNAassociated biological activity. Moreover, we showed that the ND-PEI carrier is less toxic than the ND-PAH ones.
This study shows that the efficient delivery of an oligonucleotide by a cationic solid nanoparticle consists in a compromise between (i) a sufficiently strong adsorption of the biomolecule onto the particle to go through the cell membrane without loss of material,
(ii) the dissociation of the complex on the timescale of a cell division cycle, and (iii) a low cellular toxicity. Furthermore a careful selection of the cationic polymer may even serve to control the release kinetics of the siRNA.
The next step will be to test the activity of the siRNA delivered by the cationic NDs Table 1 . This is attributed to carboxylic acid groups at the diamond surface, 42 further confirmed by FTIR analysis displaying a broad band centered at 1775 cm −1 (C=O stretching bond).
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As-received NDs were dispersed in deionized water to achieve a 1 g l −1 concentration.
The suspension was sonicated 3 h, at 300 W (Vibra-Cell with a 3 mm stepped microtip) to ensure de-agglomeration. We used branched low molecular weight (800 Da) The mixtures were stirred overnight at room temperature, then washed 3 times with deionised water and centrifugated at 25,000 rpm for 1 h (Optima XL90 Ultracentrifuge, 50Ti rotor, Beckman Coulter, Inc., USA). The ND-Polymer pellet was redispersed in water, and the concentration was determined by weighting after lyophilization of 1 ml of the solution.
The size of the ND and ND-polycation complex were determined by dynamic quasi-elastic light scattering (Nano ZS, Malvern Instrument, UK). The measurements were done at 20
• C, using an aqueous solution of NDs at the concentration of 20 µg ml −1 . The zeta potential was determined with the same instrument using a solution of NDs in 1 mM NaCl at the concentration of 80 µg ml −1 . Both the size and the zeta potential values are reported in Table 1 and correspond to the average of three measurements.
After coating by PAH or PEI, the quantity of amine associated to the NDs was determined by the Kaiser method 44 as described by Vial and al. kinetics of siRNA release, the intensities of both channels was calculated using NIH ImageJ software. It can be assumed that that only FITC-labeled siRNA bound to the fNDs contributes to the green intensity, since when siRNA were released they spread all over the cytosol, and FITC signal at each pixel could not overcome autofluorescence intensity.
Colocalization studies of fNDs and siRNA were realized on a home-made scanning stage confocal microscope described in Faklaris et al. 17 equipped with single-photon counting detectors.
Biological activity tests(Real-Time quantitative PCR, Inhibition of Proteins synthesis) :
The total RNA extraction was performed as following. , where w value is indicated at the end of the legend. "M" stands for medium alone, and the "Control" experiment (first data from the left) was done on untreated A673 cells.
Tables and Figures

Supporting information
Viabillity of cells expressing EWS-Fli1 oncogene after incubation with siRNA:ND.
In addition to cell viability study on normal NIH/3T3 cells proving that the siRNA:NDpolycation complex only weakly impacts the cell viability (see main text), we also studied the viability of cells expressing EWS-Fli1 oncogene to proved that the viability is sufficiently high not to impair the measurement of the efficiency of siRNA inhibition.
Murine fibroblast stably expressing human EWS-Fli1 oncogene (NIH/3T3 EF) and human Ewing sarcoma cells (A673) were treated by increasing concentrations of NDs, cationic polymer coated NDs and siRNA bound to the cationic NDs. After 24 hours incubation, survival of NIH/3T3 EF cells was determined by a MTT assay. Figure S1 (a) shows that ND alone present a low toxicity in the experimental conditions. Adsorption of cationic polymers on ND increases their toxicity with an IC50 of 30 µg µl −1 for ND-PAH and a toxicity of about 30% for ND-PEI at concentration higher than 15 µg µl −1 . Surprisingly, the toxicity does not increase with larger ND-PEI concentrations, which might be due to the aggregation of the nanoparticles. When siRNA are adsorbed to ND-PAH or ND-PEI (at 50 nM concentration), the toxicity decreases to around 20%, for concentrations larger than 10 µg µl −1 . Similar results have been obtained with human A673 Ewing cells ( Figure S1(b) ). ND alone displays a low toxicity (less than 10%). Cationic ND-PAH or ND-PEI are more toxic with IC50s of 8 µg µl −1 and 90 µg µl −1 respectively. When siRNA are adsorbed onto the ND particles, we observe a decrease of their toxicity with an IC50 of 20 µg µl −1 for ND-PAH and a constant 20% toxicity for concentrations higher than 5 µg µl −1 for ND-PEI.
Note that the efficient inhibition of EWS-Fli1 oncogene was observed at ND-PEI concentration of 0.048 µg µl −1 (solid vertical arrow in Figure S1 ), at which a viability larger than 70% for both cell lines is measured. Similarly, a viability fraction larger than 55% is obtained in the case of the ND-PAH carrier at the concentration of 0.016 µg µl −1 used in the inhibition experiment (vertical dashed arrow). At these optimal concentration the lipofectamine carrier yields a cell viability of about 55% for NIH/3T3 EF cells ( Figure S2 ).
Optimal mass of ND-polycation for a sufficient amount of siRNA:ND-PAH/PEI internalized in NIH/3T3 EF cells in culture
We determined the optimal mass of ND-polycation for a sufficient amount of siRNA:ND-PAH/PEI internalized in NIH/3T3 EF cells in culture using confocal microscopy raster scans of fNDs and FITC-labelled siRNA fluorescence. As expected, Figure S3 (b) and Figure S3 (c) show that the intracellular content of siRNA increases with the fND carrier added mass, expressed as a ratio 1:w, for a given constant amount of siRNA (50 nM). Moreover, the absence of FITC fluorescence in Figure S3 (a) proves that siRNA alone cannot enter the cells, justifying the need for a carrier. From a qualitative observation of Figure S3 , one concludes that 1:25 and 1:75 are the best siRNA:ND-PAH and siRNA:ND-PEI mass ratios respectively, among the one tested, to achieve a sufficient amount of internalized siRNA. The corresponding ND-PAH and ND-PEI concentrations of 0.016 µg µl −1 and 0.048 µg µl −1 respectively, were then selected to test EWS-Fli1 gene inhibition at the same siRNA 50 nM concentration. 
